Sort
48,018 grants matching “immunotherapy”
Tulane/LSU Pediatric AIDS Clinical Trials Unit
$814,570Tulane University Of Louisiana · U01 · FY2003 · AI
CARE Network-UCSD Clinical Center
$814,515University Of California San Diego · U10 · FY2004 · HL
Mesoscale and Nanoscale Technologies Integrated by Structures for DNA Repair Complexes (MANTIS-DRC)
$814,230John A Tainer · University Of Tx Md Anderson Can Ctr · R35 · FY2025 · CA
Uncovering the Biology of Resistance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Patient-Derived Models.
$814,050Katerina Abigail Politi · Yale University · U01 · FY2019 · CA
High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis
$813,998Hongmin Li · University Of Arizona · R01 · FY2021 · AI
Immune reconstitution following autologous and allogeneic stem cell transplant
$813,983Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
$813,788Alan David Levine · Case Western Reserve University · R01 · FY2016 · DA
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
$813,788Alan David Levine · Case Western Reserve University · R01 · FY2017 · DA
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
$813,788Alan David Levine · Case Western Reserve University · R01 · FY2020 · DA
Trinity: Transcriptome assembly for genetic and functional analysis of cancer
$813,497Eric Banks · Broad Institute, Inc. · U24 · FY2019 · CA
Developing an Oncology Workforce for the 21st Century
$813,240Olufunmilayo I Olopade · University Of Chicago · K12 · FY2023 · CA
Novel Targets for Vaccine Therapy
$813,239Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Epigenetic Therapy for Thoracic Malignancies
$813,216David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA
Targeting the miR-155 and APOE-TREM2 pathways to restore dysfunctional microglia in Alzheimerâs disease
$813,171Oleg Butovsky · Brigham And Women'S Hospital · R01 · FY2019 · AG
Project 3: Integrative approach tounderstanding the mechanism ofcostimulation
$813,158Arlene H Sharpe · Yale University · P01 · FY2017 · AI
THE CANCER EPITOPE DATABASE AND ANALYSIS RESOURCE
$813,113Alessandro Sette · La Jolla Institute For Immunology · U24 · FY2024 · CA
Cytokines in AIDS and Cancer
$813,040George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Precision administration of anti-thymocyte globulin with or without verapamil in adolescents and young adults with type 1 diabetes
$812,943Laura Jacobsen · University Of Florida · R01 · FY2025 · DK
Regulation of Tumor Oxygenation by BACH1 in Breast Cancer
$812,825Marsha R Rosner · University Of Chicago · R01 · FY2025 · CA
Generation of highly differentiated NK cells to act in synergy with broadly neutralizing antibodies to reduce the SIV reservoir and establish viral control in absence of ART
$812,810Mirko Paiardini · Emory University · R56 · FY2023 · AI
Epigenome-wide association study of childhood asthma
$812,769Pandurangan Vijayanand · La Jolla Institute For Immunology · R01 · FY2017 · AI
Cell-Type Specific Vulnerability to Tauopathy and Its Prevention in Multiple Models
$812,712Einar M Sigurdsson · New York University School Of Medicine · R01 · FY2025 · NS
Cell-Type Specific Vulnerability to Tauopathy and Its Prevention in Multiple Models
$812,712Einar M Sigurdsson · New York University School Of Medicine · R01 · FY2024 · NS
Early diagnosis and mechanistic studies of type 1 diabetes using single cell analysis
$812,694Luc Teyton · Scripps Research Institute, The · R01 · FY2019 · DK
The role of the CD58:CD2 axis in cancer immune evasion and resistance to immunotherapy
$812,586Christopher Frangieh · Columbia University Health Sciences · R01 · FY2025 · CA